Condition: Severe Aortic Valve Stenosis · Cardiovascular Diseases · Sponsor: Hospital Universitari Vall d'Hebron Research Institute
Study to evaluate the efficacy and safety of a non-invasive electrocardiographic monitoring strategy associated with early discharge in patients with conduction disorder after transfemoral TAVI implantation, and its potential benefits compared to standard care.
This description comes directly from the study's public registry record.
Bruno García del Blanco, MD, PhD · 00342746155 · bruno.garcia@vallhebron.cat
Always discuss trial participation with your own doctor first.
| Hospital Unniversitari Vall d'Hebron | Barcelona, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07456280